“The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN”. 2025. Vascular and Endovascular Review 8 (5s): 154-61. https://doi.org/10.64149/J.Ver.8.5s.154-161.